BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 29665919)

  • 1. [Effect and Clinical Significance of Bortezomib and Thalidomide on the Memory T Cells Subsets and Regulatory T Cells in Peripheral Blood of Patients with Multiple Myeloma].
    Shi LL; Li HQ; Mei JG; Zhou XG; Li F; Song P; Zhai YP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Apr; 26(2):477-483. PubMed ID: 29665919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of thalidomide on CD4(+)CD25(+) T regulatory cells in patients with multiple myeloma].
    Yang Y; Zhang WG; He AL; Yang HY; Wang JL; Tian W
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Jun; 16(3):538-42. PubMed ID: 18549624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of Thalidomide on the Ratio of Th17 to Treg Cells in Peripheral Blood and Expression of IL-17 and IL-35 in Patients with Multiple Myeloma].
    Zhao LJ; Gao S; Li X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2018 Feb; 26(1):187-191. PubMed ID: 29397841
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The clinical significance of memory T cells and its subsets in gastric cancer.
    Zhang R; Li F; Li H; Yu J; Ren X
    Clin Transl Oncol; 2014 Mar; 16(3):257-65. PubMed ID: 23793812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The subsets of dendritic cells and memory T cells correspond to indoleamine 2,3-dioxygenase in stomach tumor microenvironment.
    Li F; Huang J; Li S; Li H; Yu J; Ren X; Liu J
    Tumour Biol; 2014 Sep; 35(9):8691-8. PubMed ID: 24870595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression and prognostic value of memory T lymphocyte in patients with non-small cell lung cancer following radiotherapy].
    Hu J; Zheng L; Zhang H; Zhang S; Xu G
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2017 May; 46(5):523-528. PubMed ID: 29488720
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Flow cytometry-based enumeration and functional characterization of CD8 T regulatory cells in patients with multiple myeloma before and after lenalidomide plus dexamethasone treatment.
    Raja KR; Plasil M; Rihova L; Pelcova J; Adam Z; Hajek R
    Cytometry B Clin Cytom; 2014 Jul; 86(4):220-8. PubMed ID: 23922218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Levels of T-Lymphocyte Subsets, IL-17, IL-35 and IFN-γ in Peripheral Blood and Their Clinical Significance in Patients with Multiple Myeloma].
    Xu ZJ; Zhao D; Li FP; Wang YF; Xiao HY; Wang X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Oct; 25(5):1444-1448. PubMed ID: 29070122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunomodulatory effect of DC/CIK combined with chemotherapy in multiple myeloma and the clinical efficacy.
    Zhao X; Ji CY; Liu GQ; Ma DX; Ding HF; Xu M; Xing J
    Int J Clin Exp Pathol; 2015; 8(10):13146-55. PubMed ID: 26722513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased T regulatory cells are associated with adverse clinical features and predict progression in multiple myeloma.
    Muthu Raja KR; Rihova L; Zahradova L; Klincova M; Penka M; Hajek R
    PLoS One; 2012; 7(10):e47077. PubMed ID: 23071717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of peripheral blood T-cell subsets and regulatory T-cells in multiple myeloma patients.
    Huang LQ; Wang JX; He K; Jiang YZ; Wei ZL; Huang DP; Chu LL
    Cell Mol Biol (Noisy-le-grand); 2018 Apr; 64(5):113-117. PubMed ID: 29729703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced immune-modulatory effects of thalidomide and dexamethasone co-treatment on T cell subsets.
    Kim EJ; Lee JG; Kim JY; Song SH; Joo DJ; Huh KH; Kim MS; Kim BS; Kim YS
    Immunology; 2017 Dec; 152(4):628-637. PubMed ID: 28758197
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical Efficacy of DC and CIK Immunotherapy Combined with Chemotherapy and Its Impact on Treg Cells in Newly Diagnosed Multiple Myeloma].
    Lu G; Xing J; Liu GQ; Xu M; Zhao X; Han F; Ding HF
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Jun; 23(3):737-41. PubMed ID: 26117028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.
    Atanackovic D; Cao Y; Luetkens T; Panse J; Faltz C; Arfsten J; Bartels K; Wolschke C; Eiermann T; Zander AR; Fehse B; Bokemeyer C; Kroger N
    Haematologica; 2008 Mar; 93(3):423-30. PubMed ID: 18287134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Peripheral memory T-cell profile is modified in patients undergoing periodontal management.
    Medara N; Lenzo JC; Walsh KA; Holden JA; Reynolds EC; Darby IB; O'Brien-Simpson NM
    J Clin Periodontol; 2021 Feb; 48(2):249-262. PubMed ID: 33131124
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD45RA-Foxp3(high) activated/effector regulatory T cells in the CCR7 + CD45RA-CD27 + CD28+central memory subset are decreased in peripheral blood from patients with rheumatoid arthritis.
    Matsuki F; Saegusa J; Miyamoto Y; Misaki K; Kumagai S; Morinobu A
    Biochem Biophys Res Commun; 2013 Sep; 438(4):778-83. PubMed ID: 23747721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The success of assisted reproduction technologies in relation to composition of the total regulatory T cell (Treg) pool and different Treg subsets.
    Schlossberger V; Schober L; Rehnitz J; Schaier M; Zeier M; Meuer S; Schmitt E; Toth B; Strowitzki T; Steinborn A
    Hum Reprod; 2013 Nov; 28(11):3062-73. PubMed ID: 23925397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. WASp Deficiency Selectively Affects the TCR Diversity of Different Memory T Cell Subsets in WAS Chimeric Mice.
    Li W; Jia Y; Wang Y; Zhao Q; Yang L; Zeng T; Niu L; Dai R; Li Y; Zhao X; Wu J
    Front Immunol; 2021; 12():794795. PubMed ID: 35116029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Constitutive Lck Activity Drives Sensitivity Differences between CD8+ Memory T Cell Subsets.
    Moogk D; Zhong S; Yu Z; Liadi I; Rittase W; Fang V; Dougherty J; Perez-Garcia A; Osman I; Zhu C; Varadarajan N; Restifo NP; Frey AB; Krogsgaard M
    J Immunol; 2016 Jul; 197(2):644-54. PubMed ID: 27271569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kidney transplant recipients show an increase in the ratio of T-cell effector memory/central memory as compared to nontransplant recipients on the waiting list.
    Segundo DS; Fernández-Fresnedo G; Gago M; Beares I; Ruiz-Criado J; González M; Ruiz JC; Gómez-Alamillo C; López-Hoyos M; Arias M
    Transplant Proc; 2010 Oct; 42(8):2877-9. PubMed ID: 20970557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.